Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers
Alpha-particle radionuclide-antibody conjugates are being clinically evaluated against solid
tumors even when they moderately express the targeted markers. At this limit of lower tumor …
tumors even when they moderately express the targeted markers. At this limit of lower tumor …